Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak
Review
[키워드] adopted
adverse event
Chloroquine
clinical setting
Combination
coronavirus
coronavirus disease
COVID-19
COVID-19 outbreak
COVID-19 patient
Evidence
global pandemic
HCQ
Hydroxychloroquine
indications
Infection
management
optimal dosage
patients with COVID-19
Perspective
physician
raised
Result
Retina
Retinal safety
retinal toxicity
Rheumatic diseases
risk
SARCoV-2
SARS-CoV-2
SARS-COV-2 infection
suggested
systemic lupus erythematosus
treated
treating COVID-19
was performed
World Health Organization
[DOI] 10.1007/s10792-020-01593-0 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s10792-020-01593-0 PMC 바로가기 [Article Type] Review